Article Listing - UCB teams with OXO to ease RA drug

DRUGS AND SWEDEN'S HEALTH BILL

6 April 1992

Sales of pharmaceutical products in Sweden totaled 10 billion krone ($1.6 billion) in 1990, an increase of 1 billion krone...

MAINTENANCE ULCER THERAPY CUT URGED

6 April 1992

A team of UK gastroenterologists have called for physicians to stop treating duodenal ulcer patients with maintenance H2 antagonist therapy....

WELLCOME SHARE FLOAT "MANAGERS"

6 April 1992

Following the recent announcement of its decision to float a further bank of shares in Wellcome plc, the Wellcome Trust...

Hib VACCINE LAUNCHED IN FRANCE

6 April 1992

Pasteur Vaccins has launched HIbest, a Hemophilus influenzae type B conjugate vaccine, in France. The product is suitable for...

AUSTRALIAN PMA: MEG MIDDLETON

6 April 1992

Meg Middleton has been appointed public affairs manager for the Australian Pharmaceu-tical Manufacturers Associa-tion, in succession to Wendy Edwards.

NEW PRES AT RHONE-POULENC RORER

6 April 1992

Rhone-Poulenc Rorer Inc has named Manfred Karobath as senior vice president, RPR, and president, RPR Research and Development. He was...

MG FRANCE ATTACKS GOVT COST-CUTTING

6 April 1992

The association of doctors in France, MG France, has attacked the agreement on health care expenditures which has been...

INDIAN IBUPROFEN CHARGE DROPPED

6 April 1992

The US Department of Commerce has ceased its activities relating to claims of dumping and subsidies concerning imports into...

WALDEGRAVE GIVES MESSAGE TO UK PHARMA INDUSTY

6 April 1992

From UK Health Secretary William Waldegrave

As the UK's general election campaigning draws to a conclusion, Secretary of State for Health...

HUNGARIAN DRUGS "STILL COMPETITIVE"

6 April 1992

Despite the collapse of the Soviet market, Hungarian pharmaceutical companies have succeeded in making up for these lost sales by...